Pub Date : 2024-01-01Epub Date: 2024-02-21DOI: 10.2217/bmm-2023-0674
Xiao Cheng, Hongen Wei, Yi Liu, Yaxuan Sun, Jianxin Ye, Pengyu Lu, Bin Han
Objective: To assess the relationship between LRG1 and CD4+ T cells, cognitive impairment and neurological function in acute ischemic stroke (AIS). Methods: Plasma LRG1 was detected by ELISA in 175 patients with AIS at baseline, day (D) 1, D7, month (M) 1 and M3. Results: LRG1 was negatively related to Th2 and Treg cells and positively linked to Th17 (all p < 0.05). LRG1 increased from baseline to D1, then decreased until M3 (p < 0.001). LRG1 at each assessment point was increased in patients with cognitive impairment or poor neurological function at M3 versus those without (all p < 0.05). Conclusion: LRG1 is linked to decreased Th2 and Tregs, increased Th17, cognitive impairment and nonideal neurological function recovery in patients with AIS.
{"title":"Relation between LRG1 and CD4<sup>+</sup> T cells, cognitive impairment and neurological function in patients with acute ischemic stroke.","authors":"Xiao Cheng, Hongen Wei, Yi Liu, Yaxuan Sun, Jianxin Ye, Pengyu Lu, Bin Han","doi":"10.2217/bmm-2023-0674","DOIUrl":"10.2217/bmm-2023-0674","url":null,"abstract":"<p><p><b>Objective:</b> To assess the relationship between LRG1 and CD4<sup>+</sup> T cells, cognitive impairment and neurological function in acute ischemic stroke (AIS). <b>Methods:</b> Plasma LRG1 was detected by ELISA in 175 patients with AIS at baseline, day (D) 1, D7, month (M) 1 and M3. <b>Results:</b> LRG1 was negatively related to Th2 and Treg cells and positively linked to Th17 (all p < 0.05). LRG1 increased from baseline to D1, then decreased until M3 (p < 0.001). LRG1 at each assessment point was increased in patients with cognitive impairment or poor neurological function at M3 versus those without (all p < 0.05). <b>Conclusion:</b> LRG1 is linked to decreased Th2 and Tregs, increased Th17, cognitive impairment and nonideal neurological function recovery in patients with AIS.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"5-14"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139912035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: We aimed to explore the clinical value of MDS1 and EVI1 complex locus (MECOM) in lung adenocarcinoma (LUAD). Methods: Bioinformatics and experimental validation confirmed MECOM expression levels in LUAD. The value of MECOM was analyzed by receiver operating characteristic (ROC) curve and Cox regression analysis. Results: Serum MECOM levels were lower in LUAD and correlated with gender, TNM stage, tumor size, lymph node metastasis and distant metastasis. The ROC curve showed that the area under the curve of MECOM was 0.804 for LUAD and, of note, could reach 0.889 for advanced LUAD; specificity was up to 90%. Conclusion:MECOM may contribute to independently identifying LUAD patients, particularly in advanced stages.
{"title":"MECOM: a bioinformatics and experimentally identified marker for the diagnosis and prognosis of lung adenocarcinoma.","authors":"Anqi Li, Meng Li, Jing Wang, Jiejun Zhou, Tian Yang, Meng Fan, Kun Zhang, Hengxing Gao, Hui Ren, Mingwei Chen","doi":"10.2217/bmm-2023-0600","DOIUrl":"10.2217/bmm-2023-0600","url":null,"abstract":"<p><p><b>Objective:</b> We aimed to explore the clinical value of MDS1 and EVI1 complex locus (<i>MECOM</i>) in lung adenocarcinoma (LUAD). <b>Methods:</b> Bioinformatics and experimental validation confirmed <i>MECOM</i> expression levels in LUAD. The value of <i>MECOM</i> was analyzed by receiver operating characteristic (ROC) curve and Cox regression analysis. <b>Results:</b> Serum MECOM levels were lower in LUAD and correlated with gender, TNM stage, tumor size, lymph node metastasis and distant metastasis. The ROC curve showed that the area under the curve of MECOM was 0.804 for LUAD and, of note, could reach 0.889 for advanced LUAD; specificity was up to 90%. <b>Conclusion:</b> <i>MECOM</i> may contribute to independently identifying LUAD patients, particularly in advanced stages.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"79-91"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140027395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-09-26DOI: 10.1080/17520363.2024.2398982
Ceyda Gürhan, Ercan Saruhan, Ali Batuhan Bayırlı
Aim: To examine whether there is any difference in the levels of salivary melatonin between bruxism and nonbruxism groups and to compare the stress and anxiety levels between the two groups.Materials & methods: Patients meeting the probable bruxism criteria according to the International Consensus on the Assessment of Bruxism Criteria were included in the bruxism group. The salivary melatonin concentrations of both groups were measured using an ELISA kit. To determine the relationship between stress and bruxism, the State-Trait Anxiety Inventory (STAI) test was used.Results: The bruxism group had a significantly lower night-time salivary melatonin level than the control group (p < 0.05). No significant difference was determined between the bruxism group and the control group in respect of the STAI-T scores (p > 0.05).Conclusion: The study findings revealed a strong relationship between a low melatonin level and bruxism.
目的:研究磨牙症组与非磨牙症组之间唾液褪黑激素水平是否存在差异,并比较两组之间的压力和焦虑水平:根据磨牙症评估标准国际共识,将符合可能磨牙症标准的患者纳入磨牙症组。使用酶联免疫吸附试剂盒测定两组患者的唾液褪黑激素浓度。为了确定压力与磨牙症之间的关系,采用了状态-特质焦虑量表(STAI)测试:结果:磨牙症组的夜间唾液褪黑激素水平明显低于对照组(P P > 0.05):研究结果表明,褪黑激素水平低与磨牙症之间存在密切关系。
{"title":"Comparative evaluation of salivary melatonin levels in patients with bruxism: a case-control study.","authors":"Ceyda Gürhan, Ercan Saruhan, Ali Batuhan Bayırlı","doi":"10.1080/17520363.2024.2398982","DOIUrl":"10.1080/17520363.2024.2398982","url":null,"abstract":"<p><p><b>Aim:</b> To examine whether there is any difference in the levels of salivary melatonin between bruxism and nonbruxism groups and to compare the stress and anxiety levels between the two groups.<b>Materials & methods:</b> Patients meeting the probable bruxism criteria according to the International Consensus on the Assessment of Bruxism Criteria were included in the bruxism group. The salivary melatonin concentrations of both groups were measured using an ELISA kit. To determine the relationship between stress and bruxism, the State-Trait Anxiety Inventory (STAI) test was used.<b>Results:</b> The bruxism group had a significantly lower night-time salivary melatonin level than the control group (<i>p</i> < 0.05). No significant difference was determined between the bruxism group and the control group in respect of the STAI-T scores (<i>p</i> > 0.05).<b>Conclusion:</b> The study findings revealed a strong relationship between a low melatonin level and bruxism.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"843-851"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142341806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-09-24DOI: 10.1080/17520363.2024.2403330
Mehmet Nur Kaya, Özlem Kılıç, Ezgi Çimen Güneş, Duygu Tecer, Sedat Yılmaz
Aim: The aim of the study is to evaluate whether C-reactive protein to albumin ratio (CAR), lactate dehydrogenase to albumin ratio (LAR), ferritin to erythrocyte sedimentation rate ratio (FER), systemic immune-inflammation index (SII), prognostic nutritional index (PNI) indices and ferritin level can predict organ involvement in adult-onset Still's disease (AOSD) patients.Methods: This study was planned as a cross-sectional study. Univariate and multivariate logistic regression analyses were performed to evaluate the usefulness of ferritin level and inflammatory indices in defining organ involvement.Results: Sixty-one patients diagnosed with AOSD were included in this study. Multivariate logistic regression analyzes showed that LAR (OR 1.028, 95% CI: 1.011-1.044) (p = 0.001) index predicted lymphadenopathy involvement, CAR (OR 1.249, 95% CI: 1.087-1.435) (p = 0.002) index predicted hepatomegaly involvement, ferritin level (OR 1.004, 95% CI: 1.001-1.008) (p = 0.007) predicted splenomegaly involvement, FER (OR 1.085, 95% CI: 1.012-1.164) (p = 0.021) and PNI (OR 0.271, 95% CI: 1.132-0.553) (p < 0.001) index predicted the occurrence of serositis.Conclusion: This study showed that ferritin level, CAR, FER, PNI and LAR markers may predict organ involvement at diagnosis in AOSD patients.
{"title":"Indices and ferritin level that predict organ involvement in adult-onset Still's disease.","authors":"Mehmet Nur Kaya, Özlem Kılıç, Ezgi Çimen Güneş, Duygu Tecer, Sedat Yılmaz","doi":"10.1080/17520363.2024.2403330","DOIUrl":"10.1080/17520363.2024.2403330","url":null,"abstract":"<p><p><b>Aim:</b> The aim of the study is to evaluate whether C-reactive protein to albumin ratio (CAR), lactate dehydrogenase to albumin ratio (LAR), ferritin to erythrocyte sedimentation rate ratio (FER), systemic immune-inflammation index (SII), prognostic nutritional index (PNI) indices and ferritin level can predict organ involvement in adult-onset Still's disease (AOSD) patients.<b>Methods:</b> This study was planned as a cross-sectional study. Univariate and multivariate logistic regression analyses were performed to evaluate the usefulness of ferritin level and inflammatory indices in defining organ involvement.<b>Results:</b> Sixty-one patients diagnosed with AOSD were included in this study. Multivariate logistic regression analyzes showed that LAR (OR 1.028, 95% CI: 1.011-1.044) (<i>p</i> = 0.001) index predicted lymphadenopathy involvement, CAR (OR 1.249, 95% CI: 1.087-1.435) (<i>p</i> = 0.002) index predicted hepatomegaly involvement, ferritin level (OR 1.004, 95% CI: 1.001-1.008) (<i>p</i> = 0.007) predicted splenomegaly involvement, FER (OR 1.085, 95% CI: 1.012-1.164) (<i>p</i> = 0.021) and PNI (OR 0.271, 95% CI: 1.132-0.553) (<i>p</i> < 0.001) index predicted the occurrence of serositis.<b>Conclusion:</b> This study showed that ferritin level, CAR, FER, PNI and LAR markers may predict organ involvement at diagnosis in AOSD patients.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"899-906"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142341807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-09-04DOI: 10.1080/17520363.2024.2389038
Yuanfeng Jiang, Tao Fan
Objective: This study aimed to evaluate the predictive value of IL-6 for stroke recurrence in acute ischemic stroke.Methods: Patients who were admitted within 48 h of onset were included. At 3-month, stroke recurrence was assessed. IL-6 levels were measured in serum samples taken upon admission.Results: Out of the 305 patients, 47 (15.4%) experienced a stroke recurrence. The risk of stroke recurrence increased by 8% (OR: 1.08; 95% CI: 1.04-1.11; p < 0.001) for every 1 pg/ml increase in IL-6 serum level, both in unadjusted and adjusted analyses (6%; OR: 1.06; 95% CI: 1.02-1.10; p = 0.001).Conclusion: The study supports the usefulness of IL-6 as a predictive biomarker for stroke recurrence after acute ischemic stroke.
{"title":"IL-6 and stroke recurrence in ischemic stroke.","authors":"Yuanfeng Jiang, Tao Fan","doi":"10.1080/17520363.2024.2389038","DOIUrl":"10.1080/17520363.2024.2389038","url":null,"abstract":"<p><p><b>Objective:</b> This study aimed to evaluate the predictive value of IL-6 for stroke recurrence in acute ischemic stroke.<b>Methods:</b> Patients who were admitted within 48 h of onset were included. At 3-month, stroke recurrence was assessed. IL-6 levels were measured in serum samples taken upon admission.<b>Results:</b> Out of the 305 patients, 47 (15.4%) experienced a stroke recurrence. The risk of stroke recurrence increased by 8% (OR: 1.08; 95% CI: 1.04-1.11; <i>p</i> < 0.001) for every 1 pg/ml increase in IL-6 serum level, both in unadjusted and adjusted analyses (6%; OR: 1.06; 95% CI: 1.02-1.10; <i>p</i> = 0.001).<b>Conclusion:</b> The study supports the usefulness of IL-6 as a predictive biomarker for stroke recurrence after acute ischemic stroke.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"739-747"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-06-20DOI: 10.1080/17520363.2024.2345583
Drew Magowan, Mansour Abdulshafea, Dominic Thompson, Shri-Ishvarya Rajamoorthy, Rhiannon Owen, Dean Harris, Susan Prosser
Aim: Blood-based biomarkers have shown promise for diagnosing colorectal cancer (CRC) and adenomas (CRA). This review summarizes recent studies in this area. Methods: A literature search was undertaken for 01/01/2017-01/03/2023. Criteria included CRC, CRA, liquid-biopsy, blood-based tests and diagnosis. Results: 12,378 studies were reduced to 178 for data extraction. Sixty focused on proteomics, 53 on RNA species, 30 on cfDNA methylation, seven on antigens and autoantibodies and 28 on novel techniques. 169 case control and nine cohort studies. Number of participants ranged 100-54,297, mean age 58.26. CRC sensitivity and specificity ranged 9.10-100% and 20.40-100%, respectively. CRA sensitivity and specificity ranged 8.00-95.70% and 4.00-97.00%, respectively. Conclusion: Sensitive and specific blood-based tests exist for CRC and CRA. However, studies demonstrate heterogenous techniques and reporting quality. Further work should concentrate on validation and meta-analyzes.
{"title":"Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review.","authors":"Drew Magowan, Mansour Abdulshafea, Dominic Thompson, Shri-Ishvarya Rajamoorthy, Rhiannon Owen, Dean Harris, Susan Prosser","doi":"10.1080/17520363.2024.2345583","DOIUrl":"10.1080/17520363.2024.2345583","url":null,"abstract":"<p><p><b>Aim:</b> Blood-based biomarkers have shown promise for diagnosing colorectal cancer (CRC) and adenomas (CRA). This review summarizes recent studies in this area. <b>Methods:</b> A literature search was undertaken for 01/01/2017-01/03/2023. Criteria included CRC, CRA, liquid-biopsy, blood-based tests and diagnosis. <b>Results:</b> 12,378 studies were reduced to 178 for data extraction. Sixty focused on proteomics, 53 on RNA species, 30 on cfDNA methylation, seven on antigens and autoantibodies and 28 on novel techniques. 169 case control and nine cohort studies. Number of participants ranged 100-54,297, mean age 58.26. CRC sensitivity and specificity ranged 9.10-100% and 20.40-100%, respectively. CRA sensitivity and specificity ranged 8.00-95.70% and 4.00-97.00%, respectively. <b>Conclusion:</b> Sensitive and specific blood-based tests exist for CRC and CRA. However, studies demonstrate heterogenous techniques and reporting quality. Further work should concentrate on validation and meta-analyzes.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"493-506"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11285240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-05-24DOI: 10.1080/17520363.2024.2347192
Weiyue Zhou, Jurong Wang, Fen Tian, Ping Liu, Meiyan Li, Chunli Song, Yixin Zhang, Xiaoming Yang, Xiaohuan Nie, Yuanyuan Shi
Aim: To evaluate correlations of tumor PLK3 with clinical features and prognosis of resectable endometrial cancer (EC) patients.Methods: Tumor tissues from 200 EC patients receiving surgical resections and adjacent tissues from 50 of them were collected for PLK3 determination using immunohistochemistry.Results: Tumor PLK3 negatively linked with myometrial invasion ≥50%, lymphovascular invasion, stromal cervical invasion, and International Federation of Gynecology and Obstetrics stage (all p < 0.050). High tumor PLK3 independently related to longer disease-free survival (DFS) (p = 0.044) and overall survival (OS) (p = 0.049). Its prognostic value was also validated by time-dependent receiver operating characteristic analyses (area under curve at most timepoints was >0.700).Conclusion: Tumor PLK3 potentially reflects prolonged DFS and OS in EC patients undergoing surgical resections.
{"title":"High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer.","authors":"Weiyue Zhou, Jurong Wang, Fen Tian, Ping Liu, Meiyan Li, Chunli Song, Yixin Zhang, Xiaoming Yang, Xiaohuan Nie, Yuanyuan Shi","doi":"10.1080/17520363.2024.2347192","DOIUrl":"10.1080/17520363.2024.2347192","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate correlations of tumor PLK3 with clinical features and prognosis of resectable endometrial cancer (EC) patients.<b>Methods:</b> Tumor tissues from 200 EC patients receiving surgical resections and adjacent tissues from 50 of them were collected for PLK3 determination using immunohistochemistry.<b>Results:</b> Tumor PLK3 negatively linked with myometrial invasion ≥50%, lymphovascular invasion, stromal cervical invasion, and International Federation of Gynecology and Obstetrics stage (all p < 0.050). High tumor PLK3 independently related to longer disease-free survival (DFS) (p = 0.044) and overall survival (OS) (p = 0.049). Its prognostic value was also validated by time-dependent receiver operating characteristic analyses (area under curve at most timepoints was >0.700).<b>Conclusion:</b> Tumor PLK3 potentially reflects prolonged DFS and OS in EC patients undergoing surgical resections.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"523-533"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141854836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: The objective of this study was to explore the relationship between elevated B-type natriuretic peptide (BNP) levels and the prognosis of patients with infective endocarditis (IE) undergoing cardiac surgery. Methods: In total, 162 IE patients with recorded BNP levels upon admission were included in the present study. The primary end point was all-cause mortality. Results: Multivariate Cox analysis revealed a significant association between log BNP and all-cause mortality. Kaplan-Meier analysis revealed a poorer prognosis for patients with BNP levels ≥ the 75th percentile. Furthermore, the linear trend test indicated a significant link between BNP quartiles and the primary end point within the models. Conclusion: Elevated BNP levels upon admission could predict all-cause mortality in IE patients undergoing cardiac surgery.
{"title":"B-type natriuretic peptide levels at admission predict the prognosis of patients with infective endocarditis undergoing cardiac surgery.","authors":"Ning Sun, Junyong Zhao, Wenjian Luo, Xiaolin Luo, Shaofa Wu, Zelan Wang, Pengda Li, Jia Li, Renjie Zhou, Shulin Ou, Zhexue Qin","doi":"10.2217/bmm-2023-0590","DOIUrl":"10.2217/bmm-2023-0590","url":null,"abstract":"<p><p><b>Purpose:</b> The objective of this study was to explore the relationship between elevated B-type natriuretic peptide (BNP) levels and the prognosis of patients with infective endocarditis (IE) undergoing cardiac surgery. <b>Methods:</b> In total, 162 IE patients with recorded BNP levels upon admission were included in the present study. The primary end point was all-cause mortality. <b>Results:</b> Multivariate Cox analysis revealed a significant association between log BNP and all-cause mortality. Kaplan-Meier analysis revealed a poorer prognosis for patients with BNP levels ≥ the 75th percentile. Furthermore, the linear trend test indicated a significant link between BNP quartiles and the primary end point within the models. <b>Conclusion:</b> Elevated BNP levels upon admission could predict all-cause mortality in IE patients undergoing cardiac surgery.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"93-102"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139734529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-06-12DOI: 10.2217/bmm-2023-0453
Selcuk Ozturk, Muhammed A Dursun, Tekin Yildirim, Fatih Sargin, Zeynep G Sargin, Zeynep T Ozan
Aims: This study sought to evaluate the relationship between Helicobacter pylori infection and traditional and nontraditional lipid parameters, including atherogenic index of plasma, cardiogenic risk ratio, atherogenic coefficient and remnant cholesterol. Methods: After the application of exclusion criteria, 309 patients were allocated according to the absence (n = 52) or presence (n = 257) of H. pylori infection. Results: Total cholesterol, low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) levels were nonsignificantly higher, and HDL-C levels were nonsignificantly lower, in the H. pylori-infected patient group. Triglyceride-to-HDL-C ratio, LDL-C-to-HDL-C ratio, atherogenic index of plasma, cardiogenic risk ratio, atherogenic coefficient and remnant cholesterol were comparable among groups. Conclusion: There was no significant association between H. pylori infection and traditional and nontraditional novel lipid parameters and indices.
{"title":"Traditional and nontraditional lipid parameters in <i>Helicobacter pylori</i> infection.","authors":"Selcuk Ozturk, Muhammed A Dursun, Tekin Yildirim, Fatih Sargin, Zeynep G Sargin, Zeynep T Ozan","doi":"10.2217/bmm-2023-0453","DOIUrl":"10.2217/bmm-2023-0453","url":null,"abstract":"<p><p><b>Aims:</b> This study sought to evaluate the relationship between <i>Helicobacter pylori</i> infection and traditional and nontraditional lipid parameters, including atherogenic index of plasma, cardiogenic risk ratio, atherogenic coefficient and remnant cholesterol. <b>Methods:</b> After the application of exclusion criteria, 309 patients were allocated according to the absence (n = 52) or presence (n = 257) of <i>H. pylori</i> infection. <b>Results:</b> Total cholesterol, low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) levels were nonsignificantly higher, and HDL-C levels were nonsignificantly lower, in the <i>H. pylori</i>-infected patient group. Triglyceride-to-HDL-C ratio, LDL-C-to-HDL-C ratio, atherogenic index of plasma, cardiogenic risk ratio, atherogenic coefficient and remnant cholesterol were comparable among groups. <b>Conclusion:</b> There was no significant association between <i>H. pylori</i> infection and traditional and nontraditional novel lipid parameters and indices.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"291-300"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}